Charles Rhyee
Stock Analyst at TD Cowen
(4.50)
# 1,158
Out of 5,133 analysts
673
Total ratings
55.6%
Success rate
6.8%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Reiterated: Buy | $325 → $388 | $337.97 | +14.80% | 26 | Nov 11, 2026 | |
| CAH Cardinal Health | Rated: Buy | $280 → $304 | $281.10 | +8.15% | 41 | Nov 9, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $6 | $4.90 | +22.45% | 51 | Nov 9, 2026 | |
| TDOC Teladoc Health | Rated: Hold | $6 → $8 | $8.80 | -9.09% | 60 | Nov 9, 2026 | |
| MCK McKesson | Rated: Buy | $1,006 → $1,200 | $1,102.81 | +8.81% | 52 | Nov 5, 2026 | |
| AMWL American Well | Rated: Hold | $12 → $13 | $11.74 | +10.73% | 22 | Nov 4, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $42 → $39 | $27.99 | +39.34% | 11 | Nov 3, 2026 | |
| BTSG BrightSpring Health Services | Rated: Buy | $81 → $84 | $71.21 | +17.96% | 13 | Nov 2, 2026 | |
| FTRE Fortrea Holdings | Rated: Buy | $23 → $26 | $20.20 | +28.71% | 17 | Nov 2, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | $197 → $254 | $194.65 | +30.49% | 22 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $288 → $307 | $265.12 | +15.80% | 26 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $492 → $673 | $653.94 | +2.91% | 16 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $89.35 | +23.11% | 61 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $338 | $297.00 | +13.80% | 19 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $283 | $301.53 | -6.15% | 22 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $11 → $8 | $1.26 | +534.92% | 18 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4 → $5 | $3.56 | +40.45% | 37 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $53 → $45 | $39.47 | +14.01% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $359.03 | +11.41% | 51 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $31.65 | -27.33% | 7 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.00 | +60.00% | 21 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.44 | n/a | 21 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $34.15 | n/a | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $111.92 | n/a | 1 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $37.09 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 | $219.89 | n/a | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.000001 | n/a | 3 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $250 | $0.0001 | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $1.3 | $0.000001 | n/a | 8 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $370 → $415 | $407.46 | n/a | 6 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 → $395 | $429.69 | n/a | 5 | Apr 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $31.05 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $80 | $71.27 | n/a | 4 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $410 → $460 | $450.00 | n/a | 7 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 → $210 | $209.49 | n/a | 5 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $29 | $35.03 | n/a | 4 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $21.80 | n/a | 1 | Feb 25, 2014 |
Charles River Laboratories International
Nov 11, 2026
Reiterated: Buy
Price Target: $325 → $388
Current: $337.97
Upside: +14.80%
Cardinal Health
Nov 9, 2026
Rated: Buy
Price Target: $280 → $304
Current: $281.10
Upside: +8.15%
Evolent Health
Nov 9, 2026
Reiterated: Buy
Price Target: $6
Current: $4.90
Upside: +22.45%
Teladoc Health
Nov 9, 2026
Rated: Hold
Price Target: $6 → $8
Current: $8.80
Upside: -9.09%
McKesson
Nov 5, 2026
Rated: Buy
Price Target: $1,006 → $1,200
Current: $1,102.81
Upside: +8.81%
American Well
Nov 4, 2026
Rated: Hold
Price Target: $12 → $13
Current: $11.74
Upside: +10.73%
Waystar Holding
Nov 3, 2026
Reiterated: Buy
Price Target: $42 → $39
Current: $27.99
Upside: +39.34%
BrightSpring Health Services
Nov 2, 2026
Rated: Buy
Price Target: $81 → $84
Current: $71.21
Upside: +17.96%
Fortrea Holdings
Nov 2, 2026
Rated: Buy
Price Target: $23 → $26
Current: $20.20
Upside: +28.71%
ICON Public Limited Company
Oct 29, 2026
Reiterated: Buy
Price Target: $197 → $254
Current: $194.65
Upside: +30.49%
Oct 29, 2026
Reiterated: Buy
Price Target: $288 → $307
Current: $265.12
Upside: +15.80%
Oct 23, 2026
Rated: Hold
Price Target: $492 → $673
Current: $653.94
Upside: +2.91%
Oct 9, 2026
Reiterated: Buy
Price Target: $110
Current: $89.35
Upside: +23.11%
Sep 30, 2026
Reiterated: Buy
Price Target: $338
Current: $297.00
Upside: +13.80%
Sep 15, 2026
Reiterated: Buy
Price Target: $283
Current: $301.53
Upside: -6.15%
Aug 12, 2026
Rated: Hold
Price Target: $11 → $8
Current: $1.26
Upside: +534.92%
Aug 11, 2026
Rated: Buy
Price Target: $4 → $5
Current: $3.56
Upside: +40.45%
Aug 10, 2026
Rated: Buy
Price Target: $53 → $45
Current: $39.47
Upside: +14.01%
Aug 9, 2026
Reiterated: Buy
Price Target: $400
Current: $359.03
Upside: +11.41%
Aug 2, 2026
Reiterated: Hold
Price Target: $23
Current: $31.65
Upside: -27.33%
May 27, 2026
Reiterated: Buy
Price Target: $8
Current: $5.00
Upside: +60.00%
Nov 13, 2025
Reiterated: Buy
Price Target: $15
Current: $3.44
Upside: n/a
Jun 11, 2025
Reiterated: Buy
Price Target: $90
Current: $34.15
Upside: n/a
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $51
Current: $111.92
Upside: n/a
Sep 9, 2024
Reiterated: Buy
Price Target: n/a
Current: $37.09
Upside: n/a
Oct 30, 2023
Reiterated: Buy
Price Target: $170
Current: $219.89
Upside: n/a
Dec 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 16, 2022
Reiterated: Buy
Price Target: $2 → $250
Current: $0.0001
Upside: n/a
May 17, 2022
Reiterated: Sell
Price Target: $9 → $1.3
Current: $0.000001
Upside: n/a
Apr 16, 2021
Reiterated: Buy
Price Target: $370 → $415
Current: $407.46
Upside: n/a
Apr 14, 2021
Reiterated: Buy
Price Target: $360 → $395
Current: $429.69
Upside: n/a
Mar 29, 2021
Initiated Coverage: Hold
Price Target: $29
Current: $31.05
Upside: n/a
Feb 8, 2021
Reiterated: Buy
Price Target: $74 → $80
Current: $71.27
Upside: n/a
Feb 1, 2021
Reiterated: Hold
Price Target: $410 → $460
Current: $450.00
Upside: n/a
Jun 16, 2020
Upgraded: Buy
Price Target: $200 → $210
Current: $209.49
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: $30 → $29
Current: $35.03
Upside: n/a
Feb 25, 2014
Initiated Coverage: Buy
Price Target: $42
Current: $21.80
Upside: n/a